North America, Europe & Asia Pacific Legal Cannabis Market Size, Share & Trends Report

North America, Europe & Asia Pacific Legal Cannabis Market Size, Share & Trends Analysis Report By Product Type (Hemp Oil, Marijuana), By Application, By Region, And Segment Forecasts, 2020 - 2026

  • Published Date: Jun, 2020
  • Base Year for Estimate: 2019
  • Report ID: GVR-4-68038-768-1
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2018
  • Number of Pages: 100

Table of Contents

Chapter 1 Executive Summary
                 1.1 Market Summary
Chapter 2 Legal Cannabis Market: Variables, Trends & Scope
                 2.1 Estimated Number of Cannabis Users from 2016 to 2026, by Country
                     2.1.1 Estimated Number of Medical Marijuana Users from 2016 to 2026, by Country
                 2.2 Legal Cannabis Regulatory Scenario, By Country
                     2.2.1 Australia
                         2.2.1.1 Overview
                         2.2.1.2 Cultivation
                         2.2.1.3 Manufacturing
                         2.2.1.4 Regulatory Bodies Involved
                     2.2.2 U.S.
                         2.2.2.1 Overview
                         2.2.2.2 Cultivation
                         2.2.2.3 Regulatory Bodies Involved
                     2.2.3 Canada
                         2.2.3.1 Overview
                         2.2.3.2 Cultivation
                         2.2.3.3 Production
                         2.2.3.4 Regulatory Bodies Involved
                     2.2.4 Germany
                         2.2.4.1 Overview
                         2.2.4.2 Cultivation/Production
                         2.2.4.3 Regulatory Bodies Involved
                     2.2.5 Italy
                         2.2.5.1 Overview
                         2.2.5.2 Cultivation
                         2.2.5.3 Regulatory Bodies Involved
                     2.2.6 The Netherlands
                         2.2.6.1 Overview
                         2.2.6.2 Cultivation
                         2.2.6.3 Regulatory Bodies Involved
                     2.2.7 Czech Republic
                         2.2.7.1 Overview
                         2.2.7.2 Cultivation/Production
                         2.2.7.3 Regulatory Bodies Involved
                     2.2.8 Poland
                         2.2.8.1 Overview
                         2.2.8.2 Cultivation/Production
                         2.2.8.3 Regulatory Bodies Involved
                     2.2.9 Switzerland
                         2.2.9.1 Overview
                         2.2.9.2 Cultivation/Production
                         2.2.9.3 Regulatory Bodies Involved
                     2.2.10 New Zealand
                         2.2.10.1 Overview
                         2.2.10.2 Cultivation/Production
                         2.2.10.3 Regulatory Bodies Involved
                     2.2.11 Thailand
                         2.2.11.1 Overview
                         2.2.11.2 Cultivation/Production
                         2.2.11.3 Regulatory Bodies Involved
                     2.2.12 Japan
                         2.2.12.1 Overview
                         2.2.12.2 Cultivation/Production
                         2.2.12.3 Regulatory Bodies Involved
                     2.2.13 South Korea
                         2.2.13.1 Overview
                         2.2.13.2 Cultivation/Production
                         2.2.13.3 Regulatory Bodies Involved
                 2.3 Market Dynamics
                     2.3.1 Market Driver Analysis
                         2.3.1.1 Growing legalization of medical marijuana in various countries
                         2.3.1.2 Growing adoption of medical marijuana for treatment of chronic diseases
                         2.3.1.3 Increasing demand of cannabis driving cannabis cultivation across the globe
                         2.3.1.4 Elimination of black market through legalization of medical marijuana
                         2.3.1.5 Impending legalization of marijuana for recreational/adult use
                         2.3.1.6 Increasing need for potent cannabis and recent technological advancements
                         2.3.1.7 Increasing preference towards cannabis extracts such as oils and tinctures
                         2.3.1.8 Growing legalization of cannabis-based CBD products
                         2.3.1.9 Growing adoption of CBD-based products for treating various medical conditions
                         2.3.1.10 Rise in the number of retailers selling CBD-based products
                     2.3.2 Market Restraint Analysis
                         2.3.2.1 Absence of legalization programs in several Asian and African countries
                         2.3.2.2 Strict government regulations
                         2.3.2.3 Legalization of medical cannabis only for selected indications
                         2.3.2.4 High pricing of medical cannabis
                         2.3.2.5 High pricing of cannabis compared to illegal markets in the U.S.
                         2.3.2.6 Illicit cananbis trade
                     2.3.3 Industry Challenges
                         2.3.3.1 Incomplete evidence regarding the effectiveness of medical marijuana
                         2.3.3.2 Reluctance of doctors to prescribe cannabis
                         2.3.3.3 Lower market access to cannabis due to absence of legalization programs, leading to smuggling
                 2.4 Industry Analysis -SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
                     2.4.1 Political and Legal Landscape
                     2.4.2 Economic and Social Landscape
                     2.4.3 Technology Landscape
                 2.5 Cannabinoid Summary
                     2.5.1 Cannabidiol (CBD)
                     2.5.2 Tetrahydrocannabinol (THC)
                     2.5.3 Cannbinol (CBN)
                     2.5.4 CBG
                     2.5.5 Terpenes
                     2.5.6 Flavonoids
                     2.5.7 cannabinoid Acids
                     2.5.8 Entourage Effect
                 2.6 Analysis on Mode of Ingestion
                 2.7 Cannabis Pricing Analysis, By Country, 2019 - 2026 (USD)
Chapter 3 Legal Cannabis Market: Product Type Estimates & Trend Analysis
                 3.1 Market Definition
                 3.2 Legal Cannabis Market: Product Type Movement Analysis
                 3.3 Legal Cannabis Market: Product Type Analysis
                     3.3.1 Hemp Oil (Whole Plant/CBD Oil)
                         3.3.1.1 Hemp Oil (Whole Plant/CBD Oil) Market Estimates and Forecasts, 2016 - 2026 (USD Million)
                     3.3.2 Marijuana
                         3.3.2.1 Marijuana Market Estimates and Forecasts, 2016 - 2026 (USD Million)
                         3.3.2.2 Flower
                         3.3.2.3 Oil
                         3.3.2.4 Tincture
Chapter 4 Cannabis Opportunity Analysis
                 4.1 Chronic Pain
                     4.1.1 Global Chronic Pain Therapeutics Market Estimates, Forecasts & Trends Analysis, 2016 - 2026
                     4.1.2 Global Opioid Market Estimates, Forecasts & Trends Analysis, 2016 - 2026
                     4.1.3 Estimated Number of Opioid Users from 2016 to 2026, by Country
                     4.1.4 Estimated Number of Chronic Pain Patients from 2016 to 2026, by Country
                     4.1.5 Comparative Analysis on the use of Cannabis Vs Opioid in Chronic Pain
                     4.1.6 Economic Cost Analysis on Opioid Misuse, by Country
                         4.1.6.1 U.S.
                         4.1.6.2 Canada
                         4.1.6.3 Germany
                         4.1.6.4 Italy
                         4.1.6.5 Poland
                         4.1.6.6 Czech Republic
                         4.1.6.7 Switzerland
                         4.1.6.8 Netherlands
                         4.1.6.9 Australia
                         4.1.6.10 New Zealand
                         4.1.6.11 Thailand
                         4.1.6.12 Japan
                         4.1.6.13 South Korea
                 4.2 Inflammation
                     4.2.1 Global Inflammation Therapeutics Market Size 2016 to 2026
                     4.2.2 Estimated Number of Inflammation Patients, from 2016 to 2026, by Country
                     4.2.3 Comparative Analysis on the use of Cannabis Vs Inflammation Therapeutics
                 4.3 Anxiety
                     4.3.1 Global Anxiety Therapeutics Market Size 2016 to 2026
                     4.3.2 Estimated Number of Anxiety Patients, from 2016 to 2026, by Country
                     4.3.3 Comparative Analysis on the use of Cannabis Vs Anxiety Therapeutics in Anxiety Patients
Chapter 5 Legal Cannabis Market: Application Estimates & Trend Analysis
                 5.1 Legal Cannabis Market: Application Movement Analysis
                 5.2 Legal Cannabis Market: Application Analysis
                     5.2.1 Medical Use
                         5.2.1.1 Medical Use Market Estimates and Forecasts, 2016 - 2026 (USD Million)
                         5.2.1.2 Chronic Pain
                         5.2.1.3 Anxiety
                         5.2.1.4 Inflammation
                         5.2.1.5 Sleep Disorders
                         5.2.1.6 Others
                     5.2.2 B2B Channel
                         5.2.2.1 B2B Channel Market Estimates and Forecasts, 2016 - 2026 (USD Million)
                     5.2.3 Adult Use
                         5.2.3.1 Adult use Market Estimates and Forecasts, 2016 - 2026 (USD Million)
Chapter 6 Legal Cannabis Market: Regional Estimates & Trend Analysis
                 6.1 Legal Cannabis Market: Country Analysis, 2019 & 2026
                     6.1.1 U.S.
                         6.1.1.1 U.S. Legal Cannabis Market Estimates and Forecasts, 2016 - 2026 (USD Million)
                     6.1.2 Canada
                         6.1.2.1 Canada Legal Cannabis Market Estimates and Forecasts, 2016 - 2026 (USD Million)
                     6.1.3 Germany
                         6.1.3.1 Germany Legal Cannabis Market Estimates and Forecasts, 2016 - 2026 (USD Million)
                     6.1.4 Italy
                         6.1.4.1 Italy Legal Cannabis Market Estimates And Forecasts, 2016 - 2026 (USD Million)
                     6.1.5 Poland
                         6.1.5.1 Poland Legal Cannabis Market Estimates and Forecasts, 2016 - 2026 (USD Million)
                     6.1.6 Czech Republic
                         6.1.6.1 Czech Republic Legal Cannabis Market Estimates And Forecasts, 2016 - 2026 (USD Million)
                     6.1.7 Switzerland
                         6.1.7.1 Switzerland Legal Cannabis Market Estimates and Forecasts, 2016 - 2026 (USD Million)
                     6.1.8 Netherlands
                         6.1.8.1 Netherlands Legal Cannabis Market Estimates and Forecasts, 2016 - 2026 (USD Million)
                     6.1.9 Australia
                         6.1.9.1 Australia Legal Cannabis Market Estimates and Forecasts, 2016 - 2026 (USD Million)
                     6.1.10 New Zealand
                         6.1.10.1 New Zealand Legal Cannabis Market Estimates and Forecasts, 2016 - 2026 (USD Million)
                     6.1.11 Japan
                         6.1.11.1 Japan Legal Cannabis Market Estimates and Forecasts, 2016 - 2026 (USD Million)
                     6.1.12 South Korea
                         6.1.12.1 South Korea Legal Cannabis Market Estimates and Forecasts, 2016 - 2026 (USD Million)
                     6.1.13 Thailand
                         6.1.13.1 Thailand Legal Cannabis Market Estimates and Forecasts, 2016 - 2026 (USD Million)
Chapter 7 Cannabis Pharmaceuticals Market Estimates & Trend Analysis
                 7.1 Cannabis Pharmaceuticals Market
                     7.1.1 Europe
                         7.1.1.1 Germany
                         7.1.1.2 Italy
                         7.1.1.3 Netherlands
                         7.1.1.4 Poland
                         7.1.1.5 Czech Republic
                         7.1.1.6 Switzerland
                     7.1.2 Asia Pacific
                         7.1.2.1 Australia
                         7.1.2.2 New Zealand
                         7.1.2.3 South Korea
                         7.1.2.4 Japan
Chapter 8 Cannabis Nutraceuticals Market Estimates & Trend Analysis
                 8.1 Nutraceutical Market Definition
                 8.2 Cannabis Nutraceuticals Market
                     8.2.1 Asia Pacific
                         8.2.1.1 Australia
                         8.2.1.2 New Zealand
                         8.2.1.3 Thailand
                         8.2.1.4 Japan
                         8.2.1.5 South Korea
Chapter 9 Competitive Landscape
                 9.1 Company Profiles: International Players
                     9.1.1 Canopy Growth Corporation
                         9.1.1.1 Company overview
                         9.1.1.2 Financial performance
                         9.1.1.3 Strategic initiatives
                     9.1.2 Aphria, Inc
                         9.1.2.1 Company overview
                         9.1.2.2 Financial performance
                         9.1.2.3 Strategic initiatives
                     9.1.3 Aurora Cannabis
                         9.1.3.1 Company overview
                         9.1.3.2 Financial performance
                         9.1.3.3 Strategic initiatives
                     9.1.4 Tilray
                         9.1.4.1 Company overview
                         9.1.4.2 Financial performance
                         9.1.4.3 Strategic initiatives
                     9.1.5 GW Pharmaceuticals, plc.
                         9.1.5.1 Company overview
                         9.1.5.2 Financial performance
                         9.1.5.3 Strategic initiatives
                     9.1.6 Organigram holdings Inc.
                         9.1.6.1 Company overview
                         9.1.6.2 Financial performance
                         9.1.6.3 Strategic initiatives
                     9.1.7 Lexaria Bioscience Corp.
                         9.1.7.1 Company overview
                         9.1.7.2 Financial performance
                         9.1.7.3 Strategic Initiatives
                     9.1.8 ABcann Medicinals Inc. (PArt of VIVO Cannabis Inc.)
                         9.1.8.1 Company overview
                         9.1.8.2 Financial performance
                         9.1.8.3 Strategic Initiatives
                     9.1.9 The Cronos Group
                         9.1.9.1 Company overview
                         9.1.9.2 Financial performance
                         9.1.9.3 Strategic Initiatives
                 9.2 Company Profiles: ASX Listed Cannabis Companies
                     9.2.1 AusCann Group Holdings Pty Ltd
                         9.2.1.1 Company overview
                         9.2.1.2 Strategic initiatives
                     9.2.2 Cann Group Ltd.
                         9.2.2.1 Company overview
                         9.2.2.2 Financial performance
                         9.2.2.3 Strategic initiatives
                     9.2.3 Bod Australia
                         9.2.3.1 Company Overview
                         9.2.3.2 Financial Performance
                         9.2.3.3 Strategic Initiatives
                     9.2.4 Zelira Therapeutics
                         9.2.4.1 Company Overview
                         9.2.4.2 Strategic Initiatives
                     9.2.5 Althea Group Holdings Limited
                         9.2.5.1 Company Overview
                         9.2.5.2 Financial Performance
                         9.2.5.3 Strategic Initiatives
                     9.2.6 THC Global Group Ltd
                         9.2.6.1 Company Overview
                         9.2.6.2 Financial Performance
                         9.2.6.3 Strategic Initiatives
                     9.2.7 MGC Pharmaceuticals Ltd
                         9.2.7.1 Company Overview
                         9.2.7.2 Financial Performance
                         9.2.7.3 Strategic Initiatives
                     9.2.8 Ecofibre Limited
                         9.2.8.1 Company Overview
                         9.2.8.2 Financial Performance
                         9.2.8.3 Strategic Initiatives
Chapter 10 Methodology and Scope
                 10.1 Research Methodology
                     10.1.1 Information procurement
                 10.2 Information or Data Analysis
                 10.3 Market Formulation & Validation
                     10.3.1 Region Market: CAGR Calculation
                 10.4 Region-Based Segment Share Calculation
                 10.5 List of Secondary Sources
                 10.6 List of Primary Sources


List of Tables

Table 1 Cannabis user pool analysis, by country, 2016 - 2026 (in thousands)
Table 2 Medical marijuana users pool analysis, by country, 2016 - 2026
Table 3 Average price of Marijuana per mg, by country, 2019 - 2026 (USD)
Table 4 Average price of Hemp CBD per mg, by country, 2019 - 2026 (USD)
Table 5 Opioid users pool analysis, by country, 2016 - 2026 (in thousands)
Table 6 Chronic pain patients, by country, 2016 - 2026 (in thousands)
Table 7 Inflammation patients, by country, 2016 - 2026 (in thousands)
Table 8 Anxiety patients, by country, 2016 - 2026 (in thousands)
Table 9 Europe cannabis pharmaceuticals market, by country, 2016 - 2026 (USD Million)
Table 10 Asia Pacific cannabis pharmaceuticals market, by country, 2016 - 2026 (USD Million)
Table 11 Australia cannabis nutraceuticals market, by product type, 2016 - 2026 (USD Million)
Table 12 New Zealand cannabis nutraceuticals market, by product type, 2016 - 2026 (USD Million)
Table 13 Thailand cannabis nutraceuticals market, by product type, 2016 - 2026 (USD Million)
Table 14 Japan cannabis nutraceuticals market, by product type, 2016 - 2026 (USD Million)
Table 15 South Korea cannabis nutraceuticals market, by product type, 2016 - 2026 (USD Million)
Table 16 Partial list of secondary sources
Table 17 Partial list of primary sources


List of Figures

Fig. 1 Global legal cannabis market snapshot, 2019 (USD Million)
Fig. 2 Legal cannabis market drivers impact analysis
Fig. 3 Effect of cannabis smoking vs. cannabis consumption
Fig. 4 Legal cannabis market restraints impact analysis
Fig. 5 Global cannabis-derived products mode of ingestion analysis, 2019-2026
Fig. 6 Legal cannabis market, product type outlook: Key takeaways
Fig. 7 Legal cannabis market segmentation
Fig. 8 Legal cannabis market: Product type movement analysis (2019 & 2026) (USD Million)
Fig. 9 Hemp Oil (Whole Plant/CBD Oil) market estimates and forecasts, 2016 - 2026 (USD Million)
Fig. 10 Marijuana market estimates and forecasts, 2016 - 2026 (USD Million)
Fig. 11 Flower market estimates and forecasts, 2016 - 2026 (USD Million)
Fig. 12 Oil market estimates and forecasts, 2016 - 2026 (USD Million)
Fig. 13 Tinctures market estimates and forecasts, 2016 - 2026 (USD Million)
Fig. 14 Global chronic pain therapeutics market, regional outlook: Key takeaways
Fig. 15 Chronic pain therapeutics market share, by region (2019 & 2026) (%)
Fig. 16 Global opioid market, regional outlook: Key takeaways
Fig. 17 Opioid market share, by region (2019 & 2026) (%)
Fig. 18 Global inflammation therapeutics market, regional outlook: Key takeaways
Fig. 19 Inflammation therapeutics market share, by region (2019 & 2026) (%)
Fig. 20 Global anxiety therapeutics market, regional outlook: Key takeaways
Fig. 21 Anxiety therapeutics market share, by region (2019 & 2026) (%)
Fig. 22 Legal cannabis market, application outlook: Key takeaways
Fig. 23 Legal cannabis market: Application movement analysis (2019 & 2026)
Fig. 24 Medical use market estimates and forecasts, 2016 - 2026 (USD Million)
Fig. 25 Chronic pain market estimates and forecasts, 2016 - 2026 (USD Million)
Fig. 26 Anxiety market estimates and forecasts, 2016 - 2026 (USD Million)
Fig. 27 Inflammation market estimates and forecasts, 2016 - 2026 (USD Million)
Fig. 28 Sleep Disorders market estimates and forecasts, 2016 - 2026 (USD Million)
Fig. 29 Others market estimates and forecasts, 2016 - 2026 (USD Million)
Fig. 30 B2B channel market estimates and forecasts, 2016 - 2026 (USD Million)
Fig. 31 Adult use market estimates and forecasts, 2016 - 2026 (USD Million)
Fig. 32 U.S. legal cannabis market estimates and forecasts, 2016 - 2026 (USD Million)
Fig. 33 Canada legal cannabis market estimates and forecasts, 2016 - 2026 (USD Million)
Fig. 34 Germany legal cannabis market estimates and forecasts, 2016 - 2026 (USD Million)
Fig. 35 Italy legal cannabis market estimates and forecasts, 2016 - 2026 (USD Million)
Fig. 36 Poland legal cannabis market estimates and forecasts, 2016 - 2026 (USD Million)
Fig. 37 Czech Republic legal cannabis market estimates and forecasts, 2016 - 2026 (USD Million)
Fig. 38 Switzerland legal cannabis market estimates and forecasts, 2016 - 2026 (USD Million)
Fig. 39 Netherlands legal cannabis market estimates and forecasts, 2016 - 2026 (USD Million)
Fig. 40 Australia legal cannabis market estimates and forecasts, 2016 - 2026 (USD Million)
Fig. 41 New Zealand legal cannabis market estimates and forecasts, 2016 - 2026 (USD Million)
Fig. 42 Japan legal cannabis market estimates and forecasts, 2016 - 2026 (USD Million)
Fig. 43 South Korea legal cannabis market estimates and forecasts, 2016 - 2026 (USD Million)
Fig. 44 Thailand legal cannabis market estimates and forecasts, 2016 - 2026 (USD Million)
Fig. 45 Europe cannabis pharmaceuticals market share, 2019 & 2026 (%)
Fig. 46 Germany cannabis pharmaceuticals market estimates & forecasts, 2016 - 2026 (USD Million)
Fig. 47 Italy cannabis nutraceuticals market estimates & forecasts, 2016 - 2026 (USD Million)
Fig. 48 Netherlands cannabis pharmaceuticals market estimates & forecasts, 2016 - 2026 (USD Million)
Fig. 49 Poland cannabis pharmaceuticals market estimates & forecasts, 2016 - 2026 (USD Million)
Fig. 50 Czech Republic cannabis pharmaceuticals market estimates & forecasts, 2016 - 2026 (USD Million)
Fig. 51 Switzerland cannabis pharmaceuticals market estimates & forecasts, 2016 - 2026 (USD Million)
Fig. 52 Asia Pacific cannabis nutraceuticals market share, 2019 & 2026 (%)
Fig. 53 Australia cannabis pharmaceuticals market estimates & forecasts, 2016 - 2026 (USD Million)
Fig. 54 New Zealand cannabis pharmaceuticals market estimates & forecasts, 2016 - 2026 (USD Million)
Fig. 55 South Korea cannabis pharmaceuticals market estimates & forecasts, 2016 - 2026 (USD Million)
Fig. 56 Japan cannabis pharmaceuticals market estimates & forecasts, 2016 - 2026 (USD Million)
Fig. 57 Asia Pacific cannabis nutraceuticals market share, 2019 & 2026 (%)
Fig. 58 Australia cannabis nutraceuticals market estimates & forecasts, 2016 - 2026 (USD Million)
Fig. 59 New Zealand cannabis nutraceuticals market estimates & forecasts, 2016 - 2026 (USD Million)
Fig. 60 Thailand cannabis nutraceuticals market estimates & forecasts, 2016 - 2026 (USD Million)
Fig. 61 Japan cannabis nutraceuticals market estimates & forecasts, 2016 - 2026 (USD Million)
Fig. 62 South Korea cannabis nutraceuticals market estimates & forecasts, 2016 - 2026 (USD Million)
Fig. 63 Market research process
Fig. 64 Information procurement
Fig. 65 Primary research pattern
Fig. 66 Market research approaches
Fig. 67 Value chain based sizing & forecasting
Fig. 68 QFD modeling for market share assessment
Fig. 69 Market formulation & validation

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.